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INTRODUCTION 
Cardiogenic shock (CS) is a state of inadequate tissue perfusion due to 
cardiac dysfunction.Cardiogenic shock is the most severe clinical expression of 
left ventricular failure and is associated with extensive damage to the left 
ventricular myocardium in more then 80% of STEMI patients in whom it 
occurs : the reminder have a mechanical defect such as ventricular septal or 
papillary muscle rupture or predominant right ventricular infarction .  
In the past cardiogenic shock has been reported to occur in up to 20 % of 
patients with STEMI,but estimates from recent large trails and observational 
databases report an incidence rate  in the range of 7%. This low output state is 
characterized by elevated ventricular filling pressures, low cadiac output, 
systemic hypotension and evidence of vital organ hypoperfusion .  
Between 1995 and 2004, the National Registry of Myocardial Infarction 
database recorded 300 000 ST elevation MI's of which 8.6% presented with 
Cardiogenic shock.. In patients hospitalized for either myocardial infarction, 
decompensated heart failure or following cardiac surgery, Cardiogenic shock 
was the leading cause of death resulting in mortality rates of up to 80% . 
Although rapid stabilization and treatment of reversible causes via early 
revascularization is a priority, the mortality rate due to Cardiogenic shock in 
the current era remains high. Of note, although the incidence of cardiogenic 
shock in patients with STEMI has been relatively stable since the mid -1970s, 
the short –term mortality rate has has decreased from 70 to 80 % in the 1970s 
to 50 to 60 %  in the 1990s.Cardiogenic shock is the cause of death in about 
60% of patients dying after fibrinolysis for STEMI. 
Prognostic echocardiographic factors for determination of early recovery 
after Cardiogenic shock are limited. Short and long term mortality appears to 
be associated with initial depressed LV systolic function and mitral 
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regurgitation (MR) as assessed by echocardiography. In patients with LV 
ejection fraction (EF) less than 30%, survival at one year was 24% versus 56% 
for those with preserved systolic function. 
Tissue Doppler imaging (TDI) is a sensitive, noninvasive 
echocardiographic method that records velocity of tissue motion within the 
myocardium. TDI has been evaluated in both in vitro and in vivo studies, 
allowing for the quantitative assessment of both global and regional function of 
the myocardium. Indices derived from TDI, including systolic velocity (S'), 
early (E') and late (A') diastolic velocities of the mitral annulus, are reduced in 
heart failure patients (EF < 30%) and portend a poor prognosis. Transmitral to 
early diastolic velocity ratio (E/E') obtained via TDI correlates strongly with 
LV filling pressures. An E/E' ratio > 10 identified a pulmonary capillary wedge 
pressure PCWP > 15 mm Hg with a sensitivity of 92% and a specificity of 
80%.  
The objective of this study was to describe TDI derived indices in 
patients presenting with cardiogenic shock after acute myocardial infarction but 
prior to percutaneous revascularization. 
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  AIM OF THE STUDY 
Echocardiography is widely used in the management of patients with 
cardiogenic shock (CS). Left ventricular ejection fraction (EF) has been shown 
to be an independent predictor of survival in CS. Tissue Doppler Imaging 
(TDI) is a sensitive echocardiographic technique that allows for the early 
quantitative assessment of regional left ventricular dysfunction. TDI derived 
indices, including systolic velocity (S'), early (E') and late (A') diastolic 
velocities of the mitral annulus, are reduced in heart failure patients and 
portend a poor prognosis. In addition to chronic CHF, a higher E/E' has also 
been shown to correlate with a worse prognosis in acute myocardial infarction 
and cardiogenic shock.  
The early diastolic velocity of the mitral valve annulus (e') reflects the 
rate of myocardial relaxation. When combined with measurement of the early 
transmitral flow velocity (E), the resultant ratio (E/e') correlates well with mean 
LVDP. An E/e' ratio >15 is an excellent predictor of an elevated mean LVDP 
and would predict poorer survival after acute MI. 
The objective of this study was to analyse and describe TDI derived 
indices in patients presenting with cardiogenic shock after acute myocardial 
infarction and  compare  to patients with chronic CHF and there by to assess 
the prognostic value of a noninvasive measure of left ventricular diastolic 
pressure early after acute myocardial infarction (MI). 
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REVIEW OF LITERATURE 
Echocardiography is now the most commonly used noninvasive tool for 
the assessment of cardiac anatomy and function. In addition to commonly 
established roles such as confirming diagnosis, etiologic work-up, complication 
screening, and disease monitoring, echocardiography plays an important 
clinical role in prognostic assessment. Conventional echocardiographic 
predictors of poor outcome, such as left ventricular ejection fraction and 
restrictive filling pattern have recently been supplemented by tissue Doppler 
imaging . 
Disadvantages of  Conventional Echo Imaging 
Endocardial border is not clearly defined in some pts 
 Data is dependant on  reflected signal amplitude 
Provides only semiquantative data 
Inter-observer/Intra-observer variation 
 Limited ability to detect subtle changes 
 Human eye cannot reliably visualize   time events occurring in < 90 msec for 
single image.  
Tissue Doppler imaging (TDI) is evolving as a useful echocardiographic 
tool for quantitative assessment of left ventricular (LV) systolic and diastolic 
function. Recent studies have explored the prognostic role of TDI-derived 
parameters in major cardiac diseases, such as heart failure, acute myocardial 
infarction, and hypertension. In these conditions, myocardial mitral annular 
(Sa) systolic and early diastolic (Ea) velocities have been shown to predict 
mortality or cardiovascular events.. In heart failure and after myocardial 
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infarction, noninvasive assessment of LV diastolic pressure by transmitral to 
mitral annular early diastolic velocity ratio (E/Ea) is a strong prognosticator, 
especially when E/Ea is >15. In addition, systolic intraventricular dyssynchrony 
measured by segmental analysis of myocardial velocities is another 
independent predictor of adverse clinical outcome in heart failure subjects, even 
when the QRS duration is normal. In heart failure patients who received cardiac 
resynchronization therapy, the presence of systolic dyssynchrony at baseline is 
associated with favorable LV remodeling, which in turn predicts a favorable 
long-term clinical outcome. Finally, TDI and derived deformation parameters 
improve prognostic assessment during dobutamine stress echocardiography. 
Tissue Doppler imaging is a robust and reproducible echocardiographic 
tool which has permitted a quantitative assessment of both global and regional 
function and timing of myocardial events. In clinical practice, the myocardial 
time-velocity curve can be reconstructed either on line as spectral pulsed TDI 
or off line from 2-dimensional color-coded TDI image loops. It is important to 
recognize that myocardial velocities obtained from the on-line spectral pulsed 
TDI curve are higher than those reconstructed off-line from 2D color-coded 
TDI images. Most published studies have examined the long-axis function of 
the heart by TDI from apical views.  
A number of parameters from TDI have been proposed to be useful in 
various cardiac diseases.  In systole, potentially important prognosticators of 
TDI include peak systolic velocity in ejection period measured at mitral 
annulus (Sa) as well as systolic dyssynchrony assessment. In diastole, 
potentially important prognosticators include peak myocardial early diastolic 
velocity measured at the mitral annulus (Ea)  as well as measurement of 
transmitral to TDI early diastolic velocity ratio (E/Ea). These myocardial 
velocity measurements with TDI have been shown to be useful in various 
diseases and in patients undergoing stress echocardiography for suspected 
coronary heart disease.  
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PHYSIOLOGY   
The optimal performance of the left ventricle depends on its ability to 
cycle between two states: (1) a compliant chamber in diastole that allows the 
left ventricle to fill from low LA pressure and (2) a stiff chamber (rapidly rising 
pressure) in systole that ejects the stroke volume at arterial pressures. The 
ventricle has two alternating functions: systolic ejection and diastolic filling. 
Furthermore, the stroke volume must increase in response to demand, such as 
exercise, without much increase in LA pressure.  The theoretically optimal LV 
pressure curve is rectangular, with an instantaneous rise to peak and an 
instantaneous fall to low diastolic pressures, which allows for the maximum 
time for LV filling. This theoretically optimal situation is approached by the 
cyclic interaction of myofilaments and assumes competent mitral and aortic 
valves. Diastole starts at aortic valve closure and includes LV pressure fall, 
rapid filling, diastasis and atrial contraction.  
Elevated filling pressures are the main physiologic consequence of 
diastolic dysfunction. Filling pressures are considered elevated when the mean 
pulmonary capillary wedge pressure (PCWP) is >12 mm Hg or when the 
LVEDP is >16 mm Hg. Filling pressures change minimally with exercise in 
healthy subjects. Exercise-induced elevation of filling pressures limits exercise 
capacity and can indicate diastolic dysfunction. LV filling pressures are 
determined mainly by filling and passive properties of the LV wall but may be 
further modulated by incomplete myocardial relaxation and variations in 
diastolic myocardial tone. 
At the molecular level, the cyclic interaction of myofilaments leads to a 
muscular contraction and relaxation cycle. Relaxation is the process whereby 
the myocardium returns after contraction to its unstressed length and force. In 
normal hearts, and with normal load, myocardial relaxation is nearly complete 
at minimal LV pressure. Contraction and relaxation belong to the same 
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molecular processes of transient activation of the myocyte and are closely 
intertwined. Relaxation is subjected to control by load, inactivation, and 
asynchrony. 
Increased afterload or late systolic load will delay myocardial relaxation, 
especially when combined with elevated preload, thereby contributing to 
elevating filling pressures. Myocardial inactivation relates to the processes 
underlying calcium extrusion from the cytosol and cross-bridge detachment 
and is affected by a number of proteins that regulate calcium homeostasis, 
cross-bridge cycling, and energetics. Minor regional variation of the timing of 
regional contraction and relaxation is physiological. However, dyssynchronous 
relaxation results in a deleterious interaction between early reextension in some 
segments and postsystolic shortening of other segments and contributes to 
delayed global LV relaxation and elevated filling pressures. 
Tau is a widely accepted invasive measure of the rate of LV relaxation, 
which will be 97% complete at a time corresponding to 3.5 t after dP/dtmin. 
Diastolic dysfunction is present when t > 48 ms. In addition, the rate of 
relaxation may be evaluated in terms of LV dP/dtmin and indirectly with the 
isovolumetric relaxation time (IVRT), the time interval between aortic valve 
closure and mitral valve opening. 
LV filling is determined by the interplay between LV filling pressures 
and filling properties. These filling properties are described with stiffness or 
inversely with compliance and commonly refer to end-diastolic properties. 
Several factors extrinsic and intrinsic to the left ventricle determine these end-
diastolic properties. Extrinsic factors are mainly pericardial restraint and 
ventricular interaction. Intrinsic factors include myocardial stiffness 
(cardiomyocytes and extracellular matrix), myocardial tone, chamber geometry 
and wall thickness. 
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A distinct aspect of diastolic function is related to longitudinal function 
and torsion. Torrent-Guasp et al described how the ventricles may to some 
extent be assimilated to a single myofiber band starting at the right ventricle 
below the pulmonary valve and forming a double helix extending to the left 
ventricle, where it attaches to the aorta. This double helicoidal fiber orientation 
leads to systolic twisting (torsion) and diastolic untwisting (torsional recoil). 
KEY POINTS  
1 Diastolic function is related to myocardial relaxation and passive LV 
properties and is modulated by myocardial tone. 
2 Myocardial relaxation is determined by load, inactivation, and        
nonuniformity. 
3 Myocardial stiffness is determined by the myocardial cell (eg, titin) and 
by the interstitial matrix (fibrosis). 
TISSUE DOPPLER ANNULAR EARLY AND LATE DIASTOLIC 
VELOCITIES  
A   ACQUISITION AND FEASIBILITY 
PW tissue Doppler imaging (DTI) is performed in the apical views to 
acquire mitral annular velocities. Although annular velocities can also be 
obtained by color-coded DTI, this method is not recommended, because the 
validation studies were performed using PW Doppler. The sample volume 
should be positioned at or 1 cm within the septal and lateral insertion sites of 
the mitral leaflets and adjusted as necessary usually 5-10 mm to cover the 
longitudinal excursion of the mitral annulus in both systole and diastole. 
Attention should be directed to Doppler spectral gain settings, because annular 
velocities have high signal amplitude. Most current ultrasound systems have 
tissue Doppler presets for the proper velocity scale and Doppler wall filter 
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settings to display the annular velocities. In general, the velocity scale should 
be set at about 20 cm/s above and below the zero-velocity baseline, though 
lower settings may be needed when there is severe LV dysfunction and annular 
velocities are markedly reduced (scale set to 10-15 cm/s). Minimal angulation 
(<20°) should be present between the ultrasound beam and the plane of cardiac 
motion. DTI waveforms can be obtained in nearly all patients (>95%), 
regardless of 2D image quality. It is recommended that spectral recordings be 
obtained at a sweep speed of 50 to 100 mm/s at end-expiration and that 
measurements should reflect the average of ≥3 consecutive cardiac cycles. 
B MEASUREMENTS  
Primary measurements include the systolic (S), early diastolic, and late 
diastolic velocities. The early diastolic annular velocity has been expressed as 
Ea, Em, E′, or e′, and the late diastolic velocity as Aa, Am, A′, or a′. The 
writing group favors the use of e′ and a′, because Ea is commonly used to refer 
to arterial elastance. The measurement of e′ acceleration and DT intervals, as 
well as acceleration and deceleration rates, does not appear to contain 
incremental information to peak velocity alone and need not be performed 
routinely. On the other hand, the time interval between the QRS complex and e′ 
onset is prolonged with impaired LV relaxation and can provide incremental 
information in special patient populations. For the assessment of global LV 
diastolic function, it is recommended to acquire and measure tissue Doppler 
signals at least at the septal and lateral sides of the mitral annulus and their 
average, given the influence of regional function on these velocities and time 
intervals.  
Once mitral flow, annular velocities, and time intervals are acquired, it 
is possible to compute additional time intervals and ratios. The ratios include 
annular e′/a′ and the mitral inflow E velocity to tissue Doppler e′ (E/e′) ratio. 
The latter ratio plays an important role in the estimation of LV filling pressures. 
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For time intervals, the time interval between the QRS complex and the onset of 
mitral E velocity is subtracted from the time interval between the QRS complex 
and e′ onset to derive (TE-e′), which can provide incremental information to E/e′ 
in special populations. Technically, it is important to match the RR intervals for 
measuring both time intervals time to E and time to e′ and to optimize gain and 
filter settings, because higher gain and filters can preclude the correct 
identification of the onset of e′ velocity. 
C HEMODYNAMIC DETERMINANTS  
The hemodynamic determinants of e′ velocity include LV relaxation 
preload, systolic function, and LV minimal pressure. A significant association 
between e′ and LV relaxation was observed in animal and human studies. For 
preload, LV filling pressures have a minimal effect on e′ in the presence of 
impaired LV relaxation. 
On the other hand, with normal or enhanced LV relaxation, preload 
increases e′. Therefore, in patients with cardiac disease, e′ velocity can be used 
to correct for the effect of LV relaxation on mitral E velocity, and the E/e′ ratio 
can be applied for the prediction of LV filling pressures. The main 
hemodynamic determinants of a′ include LA systolic function and LVEDP, 
such that an increase in LA contractility leads to increased a′ velocity, whereas 
an increase in LVEDP leads to a decrease in a’ 
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Figure 1    Tissue Doppler recording from the lateral mitral annulus from a 
normal subject aged 35 years (left) (e′ = 14 cm/s) and a 58-year-old patient with 
hypertension, LV hypertrophy, and impaired LV relaxation (right) (e′ = 8 
cm/s). 
In the presence of impaired LV relaxation and irrespective of LA 
pressure, the e′ velocity is reduced and delayed, such that it occurs at the LA-
LV pressure crossover point. On the other hand, mitral E velocity occurs earlier 
with pseudonormal LV filling  or restrictive LV filling. Accordingly, the time 
interval between the onset of E and e′ is prolonged with diastolic dysfunction. 
Animal and human studies have shown that (TE-e′) is strongly dependent on the 
time constant of LV relaxation and LV minimal pressure. 
D NORMAL VALUES  
Normal values of DTI-derived velocities are influenced by age, similar 
to other indices of LV diastolic function. With age, e′ velocity decreases, 
whereas a′ velocity and the E/e′ ratio increase. 
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Table  1 --  Normal values for Doppler-derived diastolic measurements 
 
 
Measurement 
Age group (y) 
16-20 21-40 41-60 >60 
IVRT (ms) 50 ± 9 (32-68) 67 ± 8 (51-83) 74 ± 7 (60-88) 87 ± 7 (73-101) 
E/A ratio 1.88 ± 0.45 (0.98-
2.78) 
1.53 ± 0.40 (0.73-
2.33) 
1.28 ± 0.25 (0.78-
1.78) 
0.96 ± 0.18 (0.6-
1.32) 
DT (ms) 142 ± 19 (104-
180) 
166 ± 14 (138-
194) 
181 ± 19 (143-
219) 
200 ± 29 (142-
258) 
A duration 
(ms) 
113 ± 17 (79-147) 127 ± 13 (101-
153) 
133 ± 13 (107-
159) 
138 ± 19 (100-
176) 
PV S/D ratio 0.82 ± 0.18 (0.46-
1.18) 
0.98 ± 0.32 (0.34-
1.62) 
1.21 ± 0.2 (0.81-
1.61) 
1.39 ± 0.47 
(0.45-2.33) 
PV Ar (cm/s) 16 ± 10 (1-36) 21 ± 8 (5-37) 23 ± 3 (17-29) 25 ± 9 (11-39) 
PV Ar 
duration (ms) 
66 ± 39 (1-144) 96 ± 33 (30-162) 112 ± 15 (82-142) 113 ± 30 (53-
173) 
Septal e′ 
(cm/s) 
14.9 ± 2.4 (10.1-
19.7) 
15.5 ± 2.7 (10.1-
20.9) 
12.2 ± 2.3 (7.6-
16.8) 
10.4 ± 2.1 (6.2-
14.6) 
Septal e′/a′ 
ratio 
2.4 1.6 ± 0.5 (0.6-2.6) 1.1 ± 0.3 (0.5-1.7) 0.85 ± 0.2 (0.45-
1.25) 
Lateral e′ 
(cm/s) 
20.6 ± 3.8 (13-
28.2) 
19.8 ± 2.9 (14-
25.6) 
16.1 ± 2.3 (11.5-
20.7) 
12.9 ± 3.5 (5.9-
19.9) 
Lateral e′/a′ 
ratio 
3.1 1.9 ± 0.6 (0.7-3.1) 1.5 ± 0.5 (0.5-2.5) 0.9 ± 0.4 (0.1-
1.7) 
  
Data are expressed as mean ± SD (95% confidence interval). Note that 
for e′ velocity in subjects aged 16 to 20 years, values overlap with those for 
subjects aged 21 to 40 years. This is because e′ increases progressively with 
age in children and adolescents. Therefore, the e′ velocity is higher in a normal 
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20-year-old than in a normal 16-year-old, which results in a somewhat lower 
average e′ value when subjects aged 16 to 20 years are considered. 
E CLINICAL APPLICATION  
Mitral annular velocities can be used to draw inferences about LV 
relaxation and along with mitral peak E velocity (E/e′ ratio) can be used to 
predict LV filling pressures. To arrive at reliable conclusions, it is important to 
take into consideration the age of a given patient, the presence or absence of 
cardiovascular disease, and other abnormalities noted in the echocardiogram. 
Therefore, e′ and the E/e′ ratio are important variables but should not be used as 
the sole data in drawing conclusions about LV diastolic function. 
It is preferable to use the average e′ velocity obtained from the septal 
and lateral sides of the mitral annulus for the prediction of LV filling pressures. 
Because septal e′ is usually lower than lateral e′ velocity, the E/e′ ratio using 
septal signals is usually higher than the ratio derived by lateral e′, and different 
cutoff values should be applied on the basis of LVEF, as well as e′ location. 
Although single-site measurements are sometimes used in patients with 
globally normal or abnormal LV systolic function, it is imperative to use the 
average septal and lateral e′ velocity in the presence of regional dysfunction. 
Additionally, it is useful to consider the range in which the ratio falls. Using the 
septal E/e′ ratio, a ratio < 8 is usually associated with normal LV filling 
pressures, whereas a ratio > 15 is associated with increased filling pressures. 
When the value is between 8 and 15, other echocardiographic indices should be 
used. A number of recent studies have noted that in patients with normal EFs, 
lateral tissue Doppler signals (E/e′ and e′/a′) have the best correlations with LV 
filling pressures and invasive indices of LV stiffness. These studies favor the 
use of lateral tissue Doppler signals in this population. 
TE-e′ is particularly useful in situations in which the peak e′ velocity has 
its limitations, and the average of 4 annular sites is more accurate than a single 
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site measurement for this time interval. The clinical settings in which it 
becomes advantageous to use it include subjects with normal cardiac function 
or those with mitral valve disease and when the E/e′ ratio is 8 to 15. In 
particular, an IVRT/TE-e′ ratio < 2 has reasonable accuracy in identifying 
patients with increased LV filling pressures. 
F LIMITATIONS  
There are both technical and clinical limitations. For technical 
limitations, proper attention to the location of the sample size, as well as gain, 
filter, and minimal angulation with annular motion, is essential for reliable 
velocity measurements. With experience, these are highly reproducible with 
low variability. Because time interval measurements are performed from 
different cardiac cycles, additional variability is introduced. This limits their 
application to selective clinical settings in which other Doppler measurements 
are not reliable. 
There are a number of clinical settings in which annular velocity 
measurements and the E/e′ ratio should not be used. In normal subjects, e′ 
velocity is positively related to preload and the E/e′ ratio may not provide a 
reliable estimate of filling pressures. These individuals can be recognized by 
history, normal cardiac structure and function, and the earlier or simultaneous 
onset of annular e′ in comparison with mitral E velocity. Additionally, e′ 
velocity is usually reduced in patients with significant annular calcification, 
surgical rings, mitral stenosis, and prosthetic mitral valves. It is increased in 
patients with moderate to severe primary MR and normal LV relaxation due to 
increased flow across the regurgitant valve. In these patients, the E/e′ ratio 
should not be used, but the IVRT/TE-e′ ratio can be applied. 
Patients with constrictive pericarditis usually have increased septal e′, 
due largely to preserved LV longitudinal expansion compensating for the 
limited lateral and anteroposterior diastolic excursion. Lateral e′ may be less 
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than septal e′ in this condition, and the E/e′ ratio was shown to relate inversely 
to LV filling pressures or annulus paradoxus. 
KEY POINTS  
1    PW DTI is performed in the apical views to acquire mitral annular 
velocities. 
2    The sample volume should be positioned at or 1 cm within the septal and 
lateral insertion sites of the mitral leaflets. 
3    It is recommended that spectral recordings be obtained at a sweep speed of 
50 to 100 mm/s at end-expiration and that measurements should reflect the 
average of ≥3 consecutive cardiac cycles. 
4    Primary measurements include the systolic and early (e′) and late (a′) 
diastolic velocities. 
5    For the assessment of global LV diastolic function, it is recommended to 
acquire and measure tissue Doppler signals at least at the septal and lateral 
sides of the mitral annulus and their average. 
6    In patients with cardiac disease, e′ can be used to correct for the effect of 
LV relaxation on mitral E velocity, and the E/e′ ratio can be applied for the 
prediction of LV filling pressures. 
7    The E/e′ ratio is not accurate as an index of filling pressures  in patients 
with heavy annular calcification, mitral valve disease, and constrictive 
pericarditis 
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TDI -CLINICAL APPLICATIONS 
• Assessment of  global& regional LV systolic & diastolic dysfunction 
• Quantification of regional wall motion 
• Assessment of Left Ventricular Filling Pressure 
• In Myocardial Ischemia, Infarction 
• In Myocardial Viability 
• During stress echocardiography 
• Differentiation of restrictive cardiomyopathy & constrictive pericarditis 
•  Heart failure & after cardiac transplantation 
• To differentiate pathological from physiological LV  hypertrophy. 
• Sub clinical Left Ventricular Dysfunction- RHD, Drug induced 
• To asses RV function 
TDI –ASSESSMENT OF GLOBAL SYSTOLIC FUNCTION 
• Average of 6 mitral annular velocities around mitral annulus 
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FIGURE 2 
Kazuyo Fukuda et al  J.A.S.E 1998;11:841-848
Mitral Annulus Velocity Recording
Anteroseptal
Posterior
PosteroseptalLateral
Anterior 
Inferior
 
• Normal E’ at medial annulus > 10 cm/s, lateral annulus >15 cm/sec 
• Peak systolic velocity of <7.5cm/sec correlates with an EF of <50% with 
sensitivity 79% & specificity of 88% 
• Tricuspid systolic annular velocity < 11.5 cm/s predicted RVEF <45% 
with sensitivity of 90% &specificity of 85%  
DIASTOLIC STRESS TEST  
Many patients with diastolic dysfunction have symptoms, mainly with exertion, 
because of the rise in filling pressures that is needed to maintain adequate LV 
filling and stroke volume. Therefore, it is useful to evaluate LV filling pressure 
with exercise as well, similar to the use of exercise to evaluate patients with 
coronary artery or mitral valve disease. The E/e′ ratio has been applied for that 
objective. In subjects with normal myocardial relaxation, E and e′ velocities 
increase proportionally, and the E/e′ ratio remains unchanged or is reduced. 
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However, in patients with impaired myocardial relaxation, the increase in e′ 
with exercise is much less than that of mitral E velocity, such that the E/e′ ratio 
increases. In that regard, E/e′ was shown to relate significantly to LV filling 
pressures during exercise, when Doppler echocardiography was acquired 
simultaneously with cardiac catheterization. In addition, mitral DT decreases 
slightly in normal individuals with exercise, but shortens > 50 ms in patients 
with a marked elevation of filling pressures. 
 
Table 2  --  Changes in mitral and tissue Doppler septal velocities with exercise 
in normal subjects  
Variable Baseline Exercise
E (cm/s) 73 ± 19 90 ± 25 
A (cm/s) 69 ± 17 87 ± 22 
DT (ms) 192 ± 40 176 ± 42
e′ (cm/s) 12 ± 4 15 ± 5 
E/e′ 6.7 ± 2.2 6.6 ± 2.5
 
In cardiac patients, mitral E velocity increases with exertion and stays 
increased for a few minutes after the termination of exercise, whereas e′ 
velocity remains reduced at baseline, exercise, and recovery. Therefore, E and 
e′ velocities can be recorded after exercise, after 2D images have been obtained 
for wall motion analysis. Furthermore, the delayed recording of Doppler 
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velocities avoids the merging of E and A velocities that occurs at faster heart 
rates. Exercise is usually performed using a supine bicycle protocol, and TR 
signals by CW Doppler are recorded as well to allow for the estimation of PA 
systolic pressure at rest and during exercise and recovery. Diastolic stress 
echocardiography has been also performed with dobutamine infusion, and 
restrictive filling with dobutamine was shown to provide prognostic 
information. 
The test is most useful in patients with unexplained exertional dyspnea 
who have mild diastolic dysfunction and normal filling pressures at rest. 
However, the paucity of clinical data and the potential limitations in patients 
with regional LV dysfunction, mitral valve disease, and atrial fibrillation 
preclude recommendations for its routine clinical use at this time. 
MITRAL INFLOW  
A. ACQUISITION AND FEASIBILITY  
Pulsed-wave (PW) Doppler is performed in the apical 4-chamber view 
to obtain mitral inflow velocities to assess LV filling. Color flow imaging can 
be helpful for optimal alignment of the Doppler beam, particularly when the 
left ventricle is dilated. Performing CW Doppler to assess peak E (early 
diastolic) and A (late diastolic) velocities should be performed before applying 
the PW technique to ensure that maximal velocities are obtained. A 1-mm to 3-
mm sample volume is then placed between the mitral leaflet tips during 
diastole to record a crisp velocity profile. Optimizing spectral gain and wall 
filter settings is important to clearly display the onset and cessation of LV 
inflow. Excellent-quality mitral inflow waveforms can be recorded in nearly all 
patients. Spectral mitral velocity recordings should be initially obtained at 
sweep speeds of 25 to 50 mm/s for the evaluation of respiratory variation of 
flow velocities, as seen in patients with pulmonary or pericardial disease . If 
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variation is not present, the sweep speed is increased to 100 mm/s, at end-
expiration, and averaged over 3 consecutive cardiac cycles. 
B MEASUREMENTS  
Primary measurements of mitral inflow include the peak early filling (E-
wave) and late diastolic filling (A-wave) velocities, the E/A ratio, deceleration 
time (DT) of early filling velocity, and the IVRT, derived by placing the cursor 
of CW Doppler in the LV outflow tract to simultaneously display the end of 
aortic ejection and the onset of mitral inflow. Secondary measurements include 
mitral A-wave duration obtained at the level of the mitral annulus, diastolic 
filling time, the A-wave velocity-time integral, and the total mitral inflow 
velocity-time integral with the sample volume at the level of the mitral annulus. 
Middiastolic flow is an important signal to recognize. Low velocities can occur 
in normal subjects, but when increased ≥20 cm/s, they often represent markedly 
delayed LV relaxation and elevated filling pressures. 
C NORMAL VALUES  
Age is a primary consideration when defining normal values of mitral 
inflow velocities and time intervals. With increasing age, the mitral E velocity 
and E/A ratio decrease, whereas DT and A velocity increase. Normal values are 
shown in Table 1. 
A number of variables other than LV diastolic function and filling 
pressures affect mitral inflow, including heart rate and rhythm, PR interval, 
cardiac output, mitral annular size, and LA function. Age-related changes in 
diastolic function parameters may represent a slowing of myocardial relaxation, 
which predisposes older individuals to the development of diastolic heart 
failure. 
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D INFLOW PATTERNS AND HEMODYNAMICS  
Mitral inflow patterns are identified by the mitral E/A ratio and DT. 
They include normal, impaired LV relaxation, pseudonormal LV filling (PNF), 
and restrictive LV filling. The determination of PNF may be difficult by mitral 
inflow velocities alone. Additionally, less typical patterns are sometimes 
observed, such as the triphasic mitral flow velocity flow pattern. The most 
abnormal diastolic physiology and LV filling pattern variants are frequently 
seen in elderly patients with severe and long-standing hypertension or patients 
with Hypertrophic cardiomyopathy. 
  
FIGURE 3 Schematic representation of mitral inflow, Doppler tissue imaging 
of the annulus, and pulmonary vein flow in normal and abnormal diastolic 
states. Normal mitral inflow is biphasic and consists of an early velocity (Em) 
and a late flow velocity related to atrial contraction (Am). Doppler tissue 
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imaging of the annulus results in a similar pattern of early and late (Ea and Aa) 
annular velocities opposite in direction to the mitral inflow velocity. In patients 
with normal diastolic function, both Em and Ea exceed Am and Aa. In disease-
free states, pulmonary vein flow is multiphasic, with roughly equal systolic and 
diastolic forward flow and a relatively narrow low velocity retrograde 
pulmonary vein a-wave. With varying degrees of diastolic dysfunction, there 
are predictable changes in mitral flow velocity, Doppler tissue annular 
velocities, and pulmonary vein velocities as noted in the schematic. 
It is well established that the mitral E-wave velocity primarily reflects 
the LA-LV pressure gradient during early diastole and is therefore affected by 
preload and alterations in LV relaxation. The mitral A-wave velocity reflects 
the LA-LV pressure gradient during late diastole, which is affected by LV 
compliance and LA contractile function. E-wave DT is influenced by LV 
relaxation, LV diastolic pressures following mitral valve opening, and LV 
compliance (ie, the relationship between LV pressure and volume). Alterations 
in LV end-systolic and/or end-diastolic volumes, LV elastic recoil, and/or LV 
diastolic pressures directly affect the mitral inflow velocities (ie, E wave) and 
time intervals (ie, DT and IVRT). 
E CLINICAL APPLICATION TO PATIENTS WITH DEPRESSED AND            
NORMAL EFS  
In patients with dilated cardiomyopathies, PW Doppler mitral flow 
velocity variables and filling patterns correlate better with cardiac filling 
pressures, functional class, and prognosis than LVEF. Patients with impaired 
LV relaxation filling are the least symptomatic, while a short IVRT, short 
mitral DT, and increased E/A velocity ratio characterize advanced diastolic 
dysfunction, increased LA pressure, and worse functional class. A restrictive 
filling pattern is associated with a poor prognosis, especially if it persists after 
preload reduction. Likewise, a pseudonormal or restrictive filling pattern 
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associated with acute myocardial infarction indicates an increased risk for 
heart failure, unfavorable LV remodeling, and increased cardiovascular 
mortality, irrespective of EF. 
In patients with coronary artery disease or hypertrophic cardiomyopathy, 
in whom LV EFs are ≥50%, mitral variables correlate poorly with 
hemodynamics. This may be related to the marked variation in the extent of 
delayed LV relaxation seen in these patients, which may produce variable 
transmitral pressure gradients for similar LA pressures. A restrictive filling 
pattern and LA enlargement in a patient with a normal EF are associated with a 
poor prognosis similar to that of a restrictive pattern in dilated cardiomyopathy. 
This is most commonly seen in restrictive cardiomyopathies, especially 
amyloidosis, and in heart transplant recipients. 
Key Points  
1 PW Doppler is performed in the apical 4-chamber view to obtain mitral 
inflow velocities to assess LV filling. 
2 A 1-mm to 3-mm sample volume is then placed between the mitral 
leaflet tips during diastole to record a crisp velocity profile. 
3 Primary measurements include peak E and A velocities, E/A ratio, DT, 
and IVRT. 
4 Mitral inflow patterns include normal, impaired LV relaxation, PNF, 
and restrictive LVfilling. 
5 In patients with dilated cardiomyopathies, filling patterns correlate 
better with filling pressures, functional class, and prognosis than 
LVEF. 
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6 In patients with coronary artery disease and those with hypertrophic 
cardiomyopathy in whom the LV EFs are ≥50%, mitral velocities 
correlate poorly with hemodynamics. 
ESTIMATION OF LV FILLING PRESSURES IN PATIENTS WITH 
DEPRESSED EFS  
The mitral inflow pattern by itself can be used to estimate filling 
pressures with reasonable accuracy in this population. Furthermore, the 
changes in the inflow pattern can be used to track filling pressures in response 
to medical therapy. In patients with impaired relaxation patterns and peak E 
velocities < 50 cm/s, LV filling pressures are usually normal. With restrictive 
filling, mean LA pressure is increased.  
The use of additional Doppler parameters is recommended in patients 
with E/A ratios ≥1 to <2. A change in E/A ratio with the Valsalva maneuver of 
≥0.5, a systolic peak velocity/diastolic peak velocity ratio in pulmonary venous 
flow < 1, Ar − A duration ≥ 30 ms, E/Vp ≥ 2.5, E/e′ (using average e′) ≥ 15, 
IVRT/TE-e′ < 2, and PA systolic pressure ≥ 35 mm Hg (in the absence of 
pulmonary disease) can be used to infer the presence of increased filling 
pressures. Conversely, a change in E/A ratio with the Valsalva maneuver of 
<0.5, a systolic peak velocity/diastolic peak velocity ratio in pulmonary venous 
flow > 1, Ar − A duration < 0 ms, E/Vp < 1.4, E/e′ (using average e′) < 8, 
IVRT/TE-e′ > 2, and PA systolic pressure < 30 mm Hg occur with normal filling 
pressures. In patients with pseudonormal filling, it is preferable to base the 
conclusions on ≥2 Doppler findings, giving more weight to signals with higher 
technical quality. Some LA dilatation commonly occurs in this population, 
even when LV filling pressures are normal, and therefore should not be used as 
the final arbitrator in this setting. 
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TABLE 3 SUMMARY OF STUDIES WHICH ASSESSED THE 
PROGNOSTIC IMPORTANCE OF TISSUE DOPPLER IMAGING 
(TDI) PARAMETERS IN CARDIAC DISEASES 
Author Parameters Disease Group 
Sample 
Size Duration End Point 
Predictors 
of Event 
Resting echocardiography with TDI 
Wang et al Mean Sm, 
Em, Am, 
from 4 basal 
LV 
segments 
Various 
Heart 
diseases 
353 
patients 
165 
controls 
23 months Mortality Sm<3cm/s 
Em <3cm/s, 
Am <4cm/s 
Richartz et al Sa and Ea at 
septal and 
lateral 
mitral 
annulus 
HF 40 
patients  
25 
controls 
Cross 
sectional 
study 
Acute 
Pulmonary 
edema 
Ea 
Wang et al Mean Sm, 
Em, Am 
HF 182 
patients 
48 months Cardiac 
mortality 
Sm, Em, 
Am, E/Em 
Dokainish et al E/Ea HF 116 
patients 
18 months Cardiac 
mortality 
or HF 
hospitaliza
tion 
E/Ea >15 
Yamamoto et al E/Ea, Aa HF 
 
 
 
96 
patients 
29 months Cardiac 
mortality 
or HF 
hospitaliza
tion 
E/Ea >15, 
Aa 5cm/s 
Hillis et al. E/Ea AMI 250 
patients 
13 months Mortality E/Ea >15 
Wang et al Sm. Em, 
Am 
Hyperte
ntion 
174 
patients 
19 months Cardiac 
mortality 
Sm, Em, 
Am 
AMI = acute myocardial infarction; CHD = coronary heart disease; CRT = cardiac 
resynchronization therapy; DSE = dobutamine stress echocardiography; HF = heart 
failure; IVSd = thickness of interventricular septum at end-diastole; LV = left 
ventricular; Ts-diff = maximum difference in time to peak systolic velocity; Ts-SD = 
standard deviation of time to peak systolic velocity  
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TABLE 4 POTENTIALLY USEFUL PARAMETERS OF SYSTOLIC AND  
DIASTOLIC FUNCTION BY TISSUE DOPPLER IMAGING  
Parameters Period of 
Cardiac Cycle 
Number of segments 
measured 
Sampling Level 
Systole 
Sa Ejection period Single or mean of 2 
segments 
Mitral septal or lateral 
annulus 
Sm Ejection period Single or mean of 6 basal 
segments 
Basal LV segments 
Dyssynchrony Time to peak or 
onset of Sm 
Multiple, from 2 to 12 
segments 
Basal + mid segments 
Diastole
Ea Early diastole Single or mean of 2 
segments 
Mitral septal or lateral 
annulus 
Em Early diastole Single or mean of 6 basal 
segments 
Basal LV segments 
Aa or Am Late diastole 1 or 2 for Aa, up to 6 
basal segments for Am 
Mitral annulus for Aa, 
basal segments for Am 
Ea/Aa or 
Em/Am 
Diastole 1 or 2 for Aa, up to 6 
basal segments for Am 
Mitral septral or lateral 
annulus for Ea/Aa, basal 
segment for Em/Am 
E/Ea or E/Em  Early diastole Single or 2 locations Mitral septral or lateral 
annulus for Ea/Aa, basal 
segment for Em/Am 
Aa = mitral annular velocity during late diastole; Am = myocardial segmental velocity 
during late diastole; E/Ea = transmitral to mitral annular early diastolic velocity ratio; 
E/Em = transmitral to basal septal myocardial early diastolic velocity ratio; Ea = 
mitral annular velocity during early diastole; Ea/Aa = mitral annular early to late 
diastolic velocity ratio; Em = myocardial segmental velocity during early diastole; 
Em/Am = myocardial early to late diastolic velocity ratio; LV = left ventricular; Sa = 
mitral annular systolic velocity; Sm = myocardial segmental systolic velocity.  
Tissue Doppler imaging has evolved as a new quantitative tool for the 
assessment of cardiac systolic function, diastolic function, and the 
hemodynamics of LV filling. From tissue Doppler velocity analysis, a number 
of parameters have been shown to be useful to predict long-term prognosis, in 
particular, Sm, Em, and E/Ea. The use of threshold value of  E/Ea ( 15) has 
provided independent and incremental prognostic information in a number of 
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major cardiac diseases, such as HFand acute MI. In patients with suspected 
coronary heart disease, a high basal segmental Sm value (>6 cm/s) after 
dobutamine stress echocardiography is associated with lower mortality and MI 
and is superior to wall motion score. Although a number of post-processing 
techniques can be derived from TDI, such as strain and strain rate, the clinical 
utility of these modalities as prognosticators has not been established. Because 
tissue Doppler velocity imaging is readily available in most of the current 
echocardiographic systems, this information is now ready to apply toward 
optimal clinical management for patients who are vulnerable to the 
development of cardiovascular events. 
CARDIOGENIC SHOCK 
Cardiogenic shock is the most severe clinical expression of left 
ventricular failure and is associated with extensive damage to the left 
ventricular myocardium in more than 80 percent of STEMI patients in whom it 
occurs; the remainder have a mechanical defect such as ventricular septal or 
papillary muscle rupture or predominant right ventricular infarction. In the past, 
cardiogenic shock has been reported to occur in up to 20 percent of patients 
with STEMI, but estimates from recent large trials and observational databases 
report an incidence rate in the range of 7 percent. This low-output state is 
characterized by elevated ventricular filling pressures, low cardiac output, 
systemic hypotension, and evidence of vital organ hypoperfusion . Patients 
with cardiogenic shock caused by STEMI are more likely to be older, to have a 
history of a prior MI or congestive heart failure, and to have sustained an 
anterior infarction at the time of development of shock. The incidence of 
cardiogenic shock in patients with STEMI has been relatively stable since the 
mid-1970s, the short-term mortality rate has decreased from 70 to 80 percent in 
the 1970s to 50 to 60 percent in the 1990s. Cardiogenic shock is the cause of 
death in about 60 percent of patients dying after fibrinolysis for STEMI. 
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DIAGNOSIS. 
  
            Hemodynamic monitoring has been used extensively during the last 
decades for risk stratification and guiding treatment of patients with 
cardiovascular destabilization, especially in the scenario of acute heart failure 
and cardiogenic shock 
Cardiogenic shock  is characterised by  
1)Marked & persistent (30 mts)  hypotension with SBP < 90  mm Hg  
2)Marked reduction of cardiac index (<1.8 L/min/m)  in the face of  
3)Elevated left ventricular filling pressure >18 mm Hg. 
4) With signs of hypoperfusion –oliguria ,confusion & cold extremeties 
Spurious estimates of left ventricular filling pressure based on 
measurements of the pulmonary artery wedge pressure can occur in the 
presence of marked mitral regurgitation, in which the tall V wave in the left 
atrial and pulmonary artery wedge pressure tracing elevates the mean pressure 
above left ventricular end-diastolic pressure. Accordingly, mitral regurgitation 
and other mechanical lesions such as ventricular septal defect, ventricular 
aneurysm, and pseudoaneurysm must be excluded before the diagnosis of 
cardiogenic shock caused by impairment of left ventricular function can be 
established. Mechanical complications should be suspected in any patient with 
STEMI in whom circulatory collapse occurs.  It is important to exclude 
mechanical complications because primary therapy of such lesions usually 
requires immediate operative treatment with intervening support of the 
circulation by intraaortic balloon counterpulsation 
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PATHOLOGICAL FINDINGS. 
At autopsy, more than two thirds of patients with cardiogenic shock 
demonstrate stenosis of 75 percent or more of the luminal diameter of all three 
major coronary vessels, usually including the left anterior descending coronary 
artery. Almost all patients with cardiogenic shock are found to have thrombotic 
occlusion of the artery supplying the major region of recent infarction, with 
loss of about 40 percent of the left ventricular mass. Patients who die as a 
consequence of cardiogenic shock often have “piecemeal” necrosis—that is, 
progressive myocardial necrosis from marginal extension of their infarct into 
an ischemic zone bordering on the infarction. This is generally associated with 
persistent elevation of cardiac biomarkers. Such extensions and focal lesions 
are probably in part the result of the shock state itself. Early deterioration in left 
ventricular function secondary to apparent extension of infarction may, in some 
cases, result from expansion of the necrotic zone of myocardium without actual 
extension of the necrotic process. Hydrodynamic forces that develop during 
ventricular systole can disrupt necrotic myocardial muscle bundles, with 
resultant expansion and thinning of the akinetic zone of myocardium, which in 
turn results in deterioration of overall left ventricular function. 
Other causes of cardiogenic shock in patients with STEMI include 
mechanical defects such as rupture of the ventricular septum, a papillary 
muscle, or free wall with tamponade; right ventricular infarction; or marked 
reduction of preload caused by conditions such as hypovolemia.  
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PATHOPHYSIOLOGY - CLASSIC SHOCK PARADIGM 
 
Figure 4 Classic shock paradigm, as illustrated by S. Hollenberg, is shown in 
black. The influence of the inflammatory response syndrome initiated by a 
large MI is illustrated in red. LVEDP indicates left ventricular end-diastolic 
pressure.   .  
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MANAGEMENT 
 
Of the five therapies frequently used to treat patients with cardiogenic 
shock (vasopressors, intraaortic balloon counterpulsation, fibrinolysis, PCI, and 
CABG), the first two are useful temporizing maneuvers. Surgical treatment in 
patients with cardiogenic shock aside from correcting mechanical abnormalities 
may involve bypassing occluded, as well as severely obstructed nonoccluded 
vessels. Occlusion of one major vessel can cause left ventricular dysfunction 
and hypotension, which can then lead to hypoperfusion and ischemia of 
myocardium subserved by the other diseased vessels. Left ventricular function 
can be improved by relief of this ischemia with revascularization. 
Multiple observational series of patients undergoing balloon angioplasty 
in cardiogenic shock have demonstrated improved hemodynamic status and 
suggested enhanced survival. In contrast, thrombolysis appears less effective 
when administered to patients in shock. Although thrombolysis may provide a 
survival benefit for patients, increasing rates of PCI  and declining rates of lytic 
use  were associated with declining mortality  for 25,311 shock patients in the  
National Registry of Myocardial Infarction (NRMI) database from 1995 to 
2004. In this propensity-adjusted multivariable analysis, primary PCI was 
associated with a significant reduction in hospital mortality . 
In the randomized SHOCK trial, a strategy of early revascularization 
resulted in 132 lives saved at 1 year per 1000 patients treated as compared with 
initial medical therapy followed by no or late revascularization as clinically 
determined.  
  The preferred treatment is PCI of the IRA for patients with 1- to 
2-vessel coronary artery disease (CAD) and suitable lesions. Moderate 3-vessel 
disease, ie, 100% IRA occlusion, <90% stenosis in 2 other major vessels, or 
more severe lesions in second-order vessels, may be treated with PCI of the 
IRA and staged complete revascularization, as indicated. Glycoprotein IIb/IIIa 
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antagonists and stents are recommended. Immediate CABG is the preferred 
treatment for severe 3-vessel or left main CAD. If CABG cannot be performed, 
single-vessel or multivessel PCI may be attempted. Distal embolization in the 
non–IRA territories during PCI may be disproportionately harmful in the 
setting of shock or recent shock.  Therefore, CABG is generally preferred to 
PCI when revascularization of the non–IRA artery is clinically indicated in the 
week after shock. However, early multivessel PCI may be warranted when 
shock persists despite PCI of the IRA, when CABG cannot be performed.  
ECHOCARDIOGRAPHIC PREDICTORS OF SURVIVAL IN 
CARDIOGENIC SHOCK -SUB STUDY OF SHOCK TRIAL 
From 1993 to 1998, 302 acute MI patients at 30 sites were randomized 
within 12 hours of cardiogenic shock diagnosis to either early emergency 
revascularization (ERV) or initial medical stabilization (IMS) . 
ECHOCARDIOGRAPHY 
 During the 4 years of the trial, 2D transthoracic echocardiograms were 
performed on each patient within  24 hours of randomization  and  predischarge  
The qualitative review included a complete evaluation of size and function of 
each ventricle and all valves in addition to LV regional wall motion assessment. 
A wall-motion score index was calculated by dividing the wall-motion score by 
number of segments visualized. Color Doppler of MR was graded with a 0 to 4 
scale (0=none, 1=mild, 2=moderate, 3=moderate to severe, and 4= severe). 
Mitral valve leaflet geometry and morphology were assessed for presence of 
leaflet prolapse, flail, and incomplete closure.  
Quantitative analysis included right and left atrial dimensions, LV 
dimensions, LV ejection fraction (EF), extent of LV endocardium involved by 
wall-motion abnormality, LV sphericity index, and mitral valve annular 
dimensions.. The sphericity index was calculated as a ratio of the LV 
midventricular dimension in the apical 4-chamber view and the long-axis 
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dimension. Doppler indices of LV filling were obtained from pulse-wave 
Doppler at the tips of the mitral valve and included E- and A-wave peak 
velocities, time velocity integrals, acceleration time, and deceleration time.  
 Of the early echocardiograms suitable for analysis, 82 were from the 
ERV group and 87 from the IMS patients. The characteristics of the patients 
with early echocardiograms were similar in terms of age, sex, rate of transfer 
admissions, and timing of shock and the echocardiograms.  
The findings of the early echocardiogram showed mean LVEF was 
31±11%. No significant differences in LV size or function were noted between 
the 2 groups. The wall-motion scores reflect significant regional dysfunction in 
both groups. No differences were observed between treatments. Regional 
function in the infarct zone was markedly impaired, with a mean segmental 
score approaching 3 representative of akinesis/dyskinesis.  
MR of grades 2+ to 4+ was noted in 39.1% of patients. The degree of 
MR did not differ between treatment groups (ERV mean MR grade 1.4±0.9 
versus IMS 1.3±0.9). Apical displacement of mitral leaflet coaptation, also 
known as incomplete mitral leaflet closure pattern was noted in 40% of those 
with grade 2+ to 4+ MR.                                                                                                              
ECHOCARDIOGRAPHIC VARIABLES ASSOCIATED WITH 
SURVIVAL                                                                                              
 The significant echocardiographic univariate predictors of 30-day 
survival were LVEF and severity of MR. These same variables, as well as end-
diastolic and end-systolic LV volume, were univariate predictors of 1-year 
survival .An LVEF cutoff of 28%  represents the median value. Furthermore, 
the separation of MR into those with less than grade 2+ and those with grade 2+ 
or higher provided the greatest discrimination between survivors and no 
survivors. From the early echocardiograms, the only independent multivariate 
predictors of either 30-day or 1-year mortality were MR severity (MR 2 versus 
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<2: 1-year odds ratio for death=6.64, P=0.0003) and LVEF (LVEF <28%: 1-
year odds ratio for death 4.04, P=0.005). 
PROGNOSIS AND DOPPLER ECHOCARDIOGRAPHY IN ACUTE 
CORONARY SYNDROME 
Besides its usefulness for quantification of LV systolic function, Doppler 
echocardiography provides useful information for the assessment of diastolic 
function and LV filling pressures.  
The E/e' ratio has been well validated to assess LV filling pressures .The 
threshold of E/e' > 15 identifies at best patients with mean LV diastolic 
pressures above 12 mmHg measured by micromanometer-tipped catheters. 
Raised LV filling pressures indicate a relatively load intolerant 
myocardium. This may results from major myocardial damage due to coronary 
occlusion or conversely from minor damage associated with a previous stiff LV 
chamber due to aging, hypertension, diabetes, or coronary atherosclerosis. 
These patients with increased LV filling pressures show poor outcome.  
The analysis of mitral inflow using pulsed Doppler signal recorded at the 
tips of the leaflets has a prognostic value in various cardiac diseases. Higher 
mitral E/A ratios and shorter deceleration times that define the restrictive 
pattern indicate an increased risk of adverse events after myocardial infarction. 
Similarly Temporelli et al. have also observed a poor outcome in 571 
patients enrolled in the GISSI-3 trial when mitral deceleration time is 
shortened. The propagation velocity of mitral inflow measured on M-mode 
colour Doppler echocardiography has also prognostic significance .However, 
reproducibility and quality of measurement of a colour M-mode slope that 
requires to carefully adjust the colour scale, in acute condition may be 
questionable in routine clinical practice.  
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By contrast, the direct recording of mitral annulus motion using tissue 
Doppler is easily obtained. The E/e' ratio gives a reasonable estimate of LV 
filling pressures and remains valid in the presence of sinus tachycardia, 
functional MR and preserved or depressed LV systolic function.  
IMPORTANCE OF TISSUE DOPPLER-DERIVED DIASTOLIC 
FUNCTION IN STEMI PATIENTS  
The data indicates that (i) bedside Doppler echocardiography obtained 
on admission provides prognostic information in patients with STEMI 
receiving a modern therapeutic strategy and (ii) the association between E/e' 
ratio >15 and the long-term risk of cardiac death was independent of clinical 
evidence of heart failure, as well as of renal dysfunction, blood glucose level, 
LV systolic dysfunction, and MR.  
Bedside Doppler echocardiography provides additional prognostic 
information over clinical and biological parameters that are routinely 
determined in patients presenting with STEMI.  
Current guidelines do not recommend index echocardiogram for patients 
admitted for unequivocal ACS. The present data advocate to perform index 
bedside Doppler echocardiography in the modern era of ACS management 
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STUDY DESIGN AND METHODS 
Setting                               Intensive Coronary Care Unit,  
           Department of Cardiology,  
                                         Govt Stanley Hospital, 
           Chennai-1. 
 
Study design                     Single centre, non randomized, observational and    
                                          Prospective study      
PATIENT SELECTION 
 The study population included 60 consecutive patients of which the 
population included: Group 1) 30 patients with chronic CHF as controls; and 
Group 2) 30 patients with CS. 
 The patients were of any age group and from both sexes admitted 
between May 2009 and May 2010 with a diagnosis of Acute STEMI with 
cardiogenic shock in coronary care unit (CCU) of our department. They were 
evaluated systematically for inclusion into study with history taking including 
risk factors, clinical examination and routine laboratory investigations 
including blood sugar,lipid profile, serum cardiac biomarkers ,12 lead ECG and 
bedside echocardiography. They were all included in the study after strictly 
adhering to study protocol.   
All patients received standard clinical care including monitoring of vital 
functions in a coronary care unit during the initial hospital stay .All patients 
were given chewable Aspirin 300 mg, clopidogrel 300 mg. and atorvastatin. 
Eligible patients were thrombolysed with Streptokinase 1.5 million Units over 
1 h and inotropic agents dopamine & dobutamine where used. 
The study was approved by the local institutional ethical committee 
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INCLUSION CRITERIA 
Group 1 
Patients were included in this group if they fulfilled the following 
criteria  
- The CHF group was defined as LVEF < 40%, NYHA class III or 
IV status, requiring hospitalization for decompensated heart 
failure. 
- The cause of their cardiac failure should be coronary artery 
disease in the form of prior admission for anterior wall 
myocardial infarction. 
Group 2 
  Patients were included in this group if they fulfilled the   
 following criteria  
 -Patients with Acute Anterior wall STEMI - with cardiogenic shock. 
Cardiogenic shock was diagnosed if the  patient had hypotension - a 
systolic blood pressure < 90 mmHg for at least 30 min  or the need for 
supportive measures to maintain a systolic blood pressure ≥ 90 mmHg . 
EXCLUSION CRITERIA 
-Preexisting severe co morbid conditions which may influence or 
modify the clinical course and outcome which may also preclude 
acquisition of adequate echocardiographic and other data. 
CKD 
Cor Pulmonale 
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Chronic Liver disese  
-NON STEMI 
- Atrial fibrillation 
-Second and third degree AV Block.  
-Evidence of primary myocardial or  
-Valvular heart disease 
- Ventricular septal rupture 
- Ventricular  free wall rupture and 
- Acute mitral  regurgitation with papillary muscle rupture 
- Prior  Angioplasty 
 -Proir  CABG 
CLINICAL DATA 
Death was defined as all-cause mortality during hospitalization.  
Vital signs and Killip class findings were collected at the time of 
hospital presentation.  
Killip class I was defined as the absence of congestive heart failure  that 
is patients who are free of rales and a third heart sound (S3). 
Class II patients have rales but to only a mild-moderate degree (<50 
percent of lung fields) and may or may not have an S3 and or jugular venous 
distention,  
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Class III have frank pulmonary edema and  
Class IV as cardiogenic shock. 
Patients with cardiogenic shock were identified. 
Cardiogenic shock was defined as systolic blood pressure <90 mm Hg 
for  30 min  and  a urine  output of  less than 20 ml/hr   in the setting of an acute 
ischemic insult. Patients in whom systolic blood pressure increased to >90 mm 
Hg within 1h after administration of positive inotropic agents, or patients who 
died within 1h of hypotension but met other criteria for cardiogenic shock, 
were still classified as having cardiogenic shock. 
ELECTROCARDIOGRAPHIC DATA  
STEMI was diagnosed based on following ECG Criteria and STEMI 
was later confirmed by the elevation of cardiac enzymes with CK-MB. 
ST-segment elevation of at least 0.1 mV in two or more contiguous        
 limb leads; 
At least 0.2 mV in two or more contiguous precordial leads  
Standard 12-lead electrocardiograms (ECGs) were collected at baseline 
and 90 minutes of starting streptokinase treatment, then every 24 hours until 
discharge.  
Reinfarction was defined as re elevation of CK-MB above the upper 
limit of normal and increase by at least 50% of the previous value or by the 
presence of new Q waves in the ECG. 
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ECHOCARDIOGRAPHY 
2D transthoracic ECHO and Tissue Doppler imaging were performed on 
each patient at the time of admission and repeated and or after hemodynamic 
instability. The echocardiograms were analyzed for qualitative and quantitative 
assessment. The assessments were performed with using an Aloka SSD 4000 
phased array system equipped with tissue doppler and harmonic imaging 
technology with Doppler frequency of 2.5 to 3.8 mHz.. 
The qualitative review included a complete evaluation of size and 
function of each ventricle and all valves in addition to LV regional wall motion 
assessment.  
Regional wall motion was analyzed individually on the basis of its 
motion and systolic thickening. The segments were analyzed as either 
Hyperkinetic/Normal/MildHypokinesis/Hypokinesis/Severehypokinesis/ 
Akinesis and Dyskinesis (paradoxical systolic motion)/ Aneurysmal . 
The severity of mitral regurgitation (MR) was semi-quantitatively 
graded from color-flow Doppler images in the  apical four- and two-chamber 
views .Color Doppler of MR was graded with a 0 to 4 scale (0=none, 1=mild,       
2=moderate, 3=moderate to severe, and 4= severe).  
The severity of MR was classified as 
Mild (jet area/left atrial area, 20% in the absence of wall jet),  
Moderate (jet area /left atrial area 20–40%),  
Severe (jet area/left atrial area >40%) 
Mitral valve leaflet geometry and morphology were assessed for 
presence of leaflet prolapse, flail, and incomplete closure.  
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Quantitative analysis was then performed on echocardiograms of 
sufficient quality. Measurements included LV dimensions, LV volume, LV 
ejection fraction (EF) . 
LVEF was measured by M- MODE, Modified Simpson’s method  
LVEF was stratified as  
Normal (LVEF 55%),  
Mildly reduced (45–54%), 
Moderately reduced (30–44%), 
Severely reduced (< 30%) 
Patients who had mechanical complications such as VSR, acute mitral  ,  
regurgitation with papillary muscle rupture and free wall rupture were excluded  
Diastolic dysfunction, pericardial effusion, LV thrombus, tricuspid     
regurgitation and pulmonary hypertension were noted 
Pulsed Doppler mitral inflow velocities were obtained by placing a 1–2 
mm sample volume between the tips of the mitral leaflets in the apical four-
chamber view. Spectral gain and wall filter settings were optimized to clearly 
display the onset and cessation of LV inflow .The Doppler beam was aligned 
parallel to the direction of flow. Spectral mitral velocity recordings were 
initially obtained at sweep speeds of 25 to 50 mm/s for the evaluation of 
respiratory variation of flow velocities in patients with pulmonary or 
pericardial disease. If variation is not present, the sweep speed was increased to 
100 mm/s. 
 The following variables were measured in end expiratory: 
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Peak early filling velocity (E)  
Peak filling velocity at atrial  contraction (A velocity) 
E/A ratio 
Deceleration time of the peak E velocity, defined as the slope from peak 
E extrapolated to the baseline value 
IVRT 
Restrictive mitral inflow patterns were defined as  E/A ratio >2 with a 
E-wave deceleration  time < 160 ms.  
TISSUE DOPPLER IMAGING 
TDI of the mitral annulus was obtained from the apical 4-chamber view.  
A 1.5-mm sample volume was placed at or 1 cm of  the lateral and 
 medial mitral annulus.  
Analysis was performed for the early diastolic (E’) ,late diastolic 
 velocity (A’)and  peak systolic velocity (S'). These variables were 
 analyzed individually, as the average of the medial and lateral annulus. 
All Doppler signals were recorded with at 100 mm/s.  
The average of 3 end-expiratory cycles was used.   
E/E’ Ratio was calculated.  
Mitral septal annular systolic(S’) velocity cut off value of <7.5 cm/s was 
 taken as LV dysfunction. 
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RESULTS AND DATA ANALYSIS 
Statistics 
The data are summarized as mean ± SD or number (percentage). Chi-
square or Fisher exact tests were applied to compare categorical variables. A 
Student t-testing was used to compare parameters between both groups. A p 
value < 0.05 was considered significant. The SPSS Statistical Analysis System 
was used to perform the analysis. 
Baseline characteristics  
The total population included 60 patients (mean age 59 ± 11, range 45 to 
72). Group I consisted of 30 patients (mean age 58 ± 13 years, range 45 to 69) 
with chronic CHF as controls. Group II consisted of 30 patients (mean age 60 ± 
10 years, range 46 to 72) with CS.The sex distribution in the study groups are 
as follows. total population 60 patients – 51 males & 9 females . Group I 
consisted of 30 patients -25 males (83%) & 5 females (17% ) . Group II 
consisted of 30 patients -26 males(86%) & 4 females ( 14%). 
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Diagram 1 - Sex distribution 
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The occurrence of Diabetes Mellitus in the study groups are as follows 
Group I 18 out of 30 patients (60%) and in Group II 20out of 30 patients (66%) 
had Diabetes Mellitus.    
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Diagram 2 – Diabetic population 
The occurrence of Hypertension in the study groups are as follows 
Group I 21 out of 30 patients (71%) and in Group II 23out of 30 patients (75%) 
had HT. 
 
Diagram 3 -  Hypertensive population 
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The occurrence of Dyslipidemia  in the study groups are as follows 
Group I  14 out of  30 patients (47%) and in Group II 16 out of 30 patients 
(53%) had Dyslipidemia   
 
Diagram 4 – Dyslipidemic population 
The occurrence of Smoking history   in the study groups are as follows 
Group I 21 out of 30 patients (70%) and in Group II 19 out of 30 patients 
(63%) had history of smoking. 
 
  Diagram – 5 Smoking  
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 The in-hospital mortality in the total study population  are as follows  
Group I  4 out of  30 patients (13%) and in Group II 19 out of 30 patients 
(63%).  
 
  Diagram 6 – Mortality 
Baseline characteristics are shown in Table 5. The two groups were 
similar with respect to baseline demographics and cardiovascular risk factors. 
Table  5 
Clinical findings in all patients (n = 60) 
Characteristics CHF (n = 30) CS (n = 30) p-value 
Age (y) 58 ± 13 60 ± 10 0.85 
Male Gender (%) 25 (83) 26 (86) 0.92 
Diabetes mellitus (%) 18 (60) 20(66) 0.80 
Hypertension (%) 21 (71) 23 (75) 0.78 
Dyslipidemia (%) 14 (47) 16 (53) 0.82 
Smoking history (%) 21 (70) 19 (63) 0.81 
Values are mean ± SD (percentage). CHF, congestive heart failure; CS, 
cardiogenic shock; y, years; LVEDD, EF, ejection fraction. p < 0.05* was considered 
significant. 
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Despite the difference in concomitant medication use amongst both 
groups; with all patients in the CS group being on inotropic support, the HR, 
SBP and DBP were similar for assessment of conventional diastolic and TDI 
parameters .  
The mean duration of hospital stay of the study population was 10 ± 2 
days. 
All  patients in Group I  had a past history of AWMI  and thrombolysis 
with streptokinase and none in Group II had a prior MI. 
 
Figure 5  ECG of a patient showing AWMI  
 
  The in-hospital mortality in the CHF cohort was 13% as compared to 
the CS group with an in hospital mortality of 63% and most of them were 
males , 3 out of 4 (75%) in  Group I   and 18 out of 19 (95%) in  Group II. 
 48
Echocardiographic analysis 
Table .6  Echocardiographic   variables  
2-D echocardiographic and Doppler echocardiographic findings in all patients  
(n = 60) 
Characteristics CHF (n = 30) CS (n = 30) p-value 
LVEDD (mm) 60 ± 3 58 ± 3 0.82 
EF (%) 27± 3 25± 5 0.80 
Doppler echocardiography 
Mitral E velocity 
(cm/s) 
70± 9 71 ± 7 0.73 
Mitral A velocity 
(cm/s) 
63 ± 12 65 ± 11 0.71 
E/A ratio 1.02 ± 0.2 1.03 ± 0.3 0.77 
Doppler tissue imaging 
S' (cm/s) 5 ± 1 3.0 ± 0.8 < 0.01 
E' (cm/s) 5.0 ± 1.0 3.1± 1.1 < 0.01 
A' (cm/s) 3.7 ± 1.0 3.1 ± 1.0 0.92 
E/E'  13 ± 3 21 ± 2 < 0.01 
 
Values are mean ± SD (percentage). CHF, congestive heart failure; CS, cardiogenic 
shock;  p < 0.05* was considered significant 
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The two groups were similar with respect to 2D echocardiographic 
parameters. Of the entire cohort, the mean LVEF was 25 ± 5%.  
 
Figure 6  M-Mode Echo- of a patient with AWMI showing hypokinesis of 
IVS with compensatory hyperkinesis of LVPW.  
 
Figure 7   2D echo–apical 4 chamber view. LVEF assessment by modified 
Simpson’s method. 
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The incidence of significant MR (Grade > 2+ )was present in 16% in  
Group I (5 out of 30 ) and 13% in Group II (4 out of 30) . There was no 
significant difference in mild MR ( Grade < 2+ ) between the two groups ( 7out 
of 30 )in Group I & (6 out of 30) in Group II.  The toal  (Group I  &  Group II ) 
incidence of MR in the mortality group was 66 %  (14 out of 21). 
All 60 patients had abnormal diastolic function, either having a 
pseudonormal pattern  or a delayed relaxation pattern or a restrictive filling 
pattern based on conventional diastolic parameters.Most of the  survivors  had 
either pseudonormal pattern  or a delayed relaxation pattern and most of the 
non survivors had restrictive filling pattern .  
 
Figure 8  Pulsed wave Doppler echo of mitral inflow showing  shortened 
DT  with restrictive filling pattern in a patient with AWMI who developed 
Cardiogenic Shock 
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The Doppler Echo indices  namely Earlydiastolic mitral inflow velocity 
E, Late diastolic mitral inflow velocity  and E/A ratio showed no statistical 
significant difference between the two groups - Table 6. 
Majority of patients in the survival group had Mitral deceleration time 
(DT)   of >160 ms where as DT of < 160 ms was associated with increased 
mortality . 
IVRT greater than 90 ms was observed in majority of the survival group 
and IVRT less than 70 ms was observed in most of the non survival group. 
The mitral   annular   Systolic   velocity (S’)   was significantly lower in 
Group II patients when compared to patients in Group I.  ie 3.0 + 0.8  cm/s Vs 
5.0 +  1cm /s . In Group II patients mitral annular   Systolic (S’)   was higher in 
the survivor group when compared to those patients who died of cardiogenic 
shock. ie 3 + 0.9  Vs 2 +  0.5 cm/s 
The mitral annular early diastolic (E’) velocity was significantly lower 
in  Group II patients  when compared to patients in  Group I.  ie   3.1 + 1.1 Vs 
5.0 + 1.0 cm/s . In Group II patients mitral annular early diastolic (E’)  
velocity   was  lower in the  non-survivor group . 
The E/E' ratio  was  elevated in CS patients as compared to CHF 
patients.ie  21 +  2  Vs 13 +  3 .In Group II  patients E/E' ratio  was higher in 
the mortality cohort  when compared to the survivor group  . 
Restrictive mitral inflow pattern and mitral E/E’ ratio >15 was more 
frequent in the mortality group.  
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Figure 9  TDI of the same patient as in figure 9 showing  reduced E’ value 
with raised E/E’ ratio of > 15 .The S’ value is also reduced  suggesting  LV 
dysfunction . 
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DISCUSSION 
Cardiogenic shock is the leading cause of death in patients with acute 
myocardial infarction with an in-hospital mortality rate greater than 50% to 60 
% [ 10 ] in the current era when compared to 70 % to 80 % in the 1970 ‘s. A 
variety of structural and functional abnormalities are identifiable on 
echocardiography in patients presenting with acute CS [11].  
Although Picard et al demonstrated reduced LV systolic function and 
mitral regurgitation as predictors of survival and response to early 
revascularization in CS [11], this study shows a reduction in TDI derived 
indices in CS patients. Despite similar reductions in LV systolic function, this 
study demonstrated CS patients have reduced myocardial velocities and higher 
filling pressures using TDI as compared to CHF patients. 
Mitral annular systolic velocity (S') reflects the long axis motion of the 
ventricle which is an important component of LV systolic function. Peak 
myocardial systolic velocity averaged from six sites around the mitral annulus 
correlates well with LV ejection fraction.  
A S' value greater than 7.5 cm/s had a sensitivity of 79% and a 
specificity of 88% in predicting normal global LV function [42].  
Sub-endocardial fibers make a substantial contribution to long axis 
function, and are susceptible to a variety of cardiac pathologies. Hypertension, 
coronary artery disease and CHF have been shown to negatively affect these 
fibers and reduce S'. A reduction in S' correlates with increased morbidity and 
mortality in each of these disease states [43 ,41,32]. 
In this study, CS patients had a significantly lower S' compared to CHF 
patients. Shock has severe metabolic consequences, involving mainly energy 
metabolism, substrate utilization, and acid-base regulation. As longitudinally 
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arranged subendocardial fibers are most vulnerable to ischemia and metabolic 
abnormalities, it is not an unexpected finding that LV base-apex contraction 
was abnormal in this CS population. Given the prognostic value in other 
cardiac disease states, a reduction of S' in CS may be of similar clinical 
importance in this patient population. In this study, albeit small numbers, the 
subset of patients in CS who survived demonstrated increased S' values on 
initial presentation, as compared to those who died in-hospital. 
Similar to systolic annular velocity (S'), early diastolic mitral annular 
(E') appears to be a strong independent predictor for the short and long-term 
prognosis of patients with cardiovascular disease.  
E' has been proposed as a useful index for the non-invasive evaluation of 
LV relaxation, that is relatively preload independent [17]. Recent studies have 
shown that a reduced E' predicts increased cardiovascular morbidity and 
mortality [43,13,32]. 
 Wang et al demonstrated that an E' less than 3 cm/s was the best 
prognostic marker for long-term follow up in a population of patients with 
chronic hypertension [43]. 
In the current study, E' was significantly reduced in the CS population as 
compared to chronic CHF patients. The potential mechanism for this 
abnormality may relate to the acute increase in LV wall stress due to the 
ischemic insult in the CS state. The reduced E' may be a sensitive marker of 
regional relaxation abnormality reflected in the long axis dimension that could 
potentially be evident earlier than clinical manifestations of global left 
ventricular relaxation abnormality. 
Raised LV filling pressures indicate a relatively load intolerant 
myocardium. This may result from major myocardial damage due to coronary 
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occlusion or conversely from minor damage associated with a previous stiff LV 
chamber due to aging, hypertension, diabetes, or coronary atherosclerosis 
Since E' is reduced and diastolic mitral annular increases with higher 
filling pressures, the E/E' ratio correlates well with invasive pulmonary 
capillary wedge pressure (PCWP) measurements [37,17,26]. Elevated PCWP is 
associated with a higher mortality rate after acute MI and has been shown to 
carry independent prognostic information in CHF patients [12,30].  
The E/E’ ratio has been well validated to assess LV filling pressures. 
The threshold of E/ E’ >15 identifies at best patients with mean LV diastolic 
pressures above 12 mmHg measured by micromanometer-tipped catheters. 
Doppler echocardiography provides useful information regarding LV 
filling pressure. Ommen et al. have previously reported that ratio of early 
transmitral flow (E) to early mitral annulus velocities (E’) >15 indicates 
elevated LV end diastolic pressure measured by cardiac catheterization and 
associated with poor prognosis. Other investigators have observed a poor 
outcome in a retrospective cohort of patients with ACS when E/ E’ ratio is >15. 
These patients with increased LV filling pressures show poor outcome 
in this study .In addition, the direct recording of mitral annulus motion using 
tissue Doppler is easily obtained. The E/ E’ ratio gives a reasonable estimate of 
LV filling pressures and remains valid in the presence of sinus tachycardia, 
functional MR, and preserved or depressed LV systolic function. 
In this study, CS patients had an elevated E/E' ratio confirming raised 
LV filling pressures. The spectrum of diastolic abnormalities which may 
account for the elevated ratios include increased myocardial stiffness, reduced 
LV compliance, and elevated LV end-diastolic parameters. A restricted filling 
pattern tends to correlate with higher mortality at 30 days and 1 year in CS 
[12], and is known to be associated with a poor prognosis in CHF patients [32]. 
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Hillis et al. previously established that in the setting of acute MI, an E/E' ratio 
greater than 15 can identify patients at an increased risk of mortality with a 
sensitivity of 70% and a specificity of 91% [30,29]. In addition, the prognostic 
value of E/E' was incremental to clinical factors and conventional 
echocardiographic parameters of LV systolic and diastolic function [30,25]. An 
elevated E/E' ratio in CS patients may be of comparable value in distinguishing 
this select population at higher risk for poor cardiovascular outcomes [8]. 
The present data indicate that the association between E/E’ ratio >15 and high 
mortality and morbidity independent of clinical evidence of heart failure, LV 
systolic dysfunction and MR. 
The E/E' ratio is superior to conventional parameters of LV systolic 
function, such as LVEF for prediction of prognosis. However, it is important to 
recognize that measurement of E/E' provides complementary prognostic data, 
with the maximum information obtained by combining this with clinical, 
systolic, and conventional diastolic parameters. 
Limitations 
Similar to other studies using TDI, this methodology is affected by the 
quality of 2D images and cardiac translation, rotation, or both. 
 The reduced LV systolic function in the CS population may have 
represented myocardial stunning, and thus the true LVEF may have been 
underestimated in this subgroup.  
Tissue Doppler imaging parameters was not obtained immediately 
following revascularization nor at 6 month followup in the patient population.  
Lastly, this study is limited by the relatively small sample size and a 
larger, prospective study is needed in order to make more substantive 
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conclusions regarding the clinical utility of tissue Doppler indices prior to 
percutaneous revascularization in patients with cardiogenic shock 
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CONCLUSION 
-Besides Bedside 2-D and Doppler echocardiography, TDI provides 
additional prognostic information over clinical and biological parameters that 
are routinely determined in patients presenting with STEMI- CS 
-Systolic annular velocity (S') correlates with LV systolic function. 
 -A Systolic annular velocity S' value greater than 7.5 cm/s predicts 
 normal global LV function. 
 -A reduction of systolic annular velocity (S') occurs both in patients 
 with  CHF and in patients with CS . 
  -The reduction of Systolic annular velocity (S') is greater in patients 
 with CS than in patients with CHF. 
 -Patients who have survived of CS demonstrate comparatively 
 increased systolic annular velocity (S') values than those who died in 
 -hospital.  
- Mitral annular early diastolic velocity E' was significantly reduced in 
the CS population as compared to chronic CHF patients 
 - The reduced E' is a sensitive marker of regional relaxation abnormality 
  reflected in the long axis dimension  
 -E' gets reduced and diastolic mitral annular increases with higher filling 
 pressures and the E/E' ratio correlates well with raised LV filling 
 pressures.  
 - E/E' ratio in the setting of acute MI -CS greater than 15 can identify 
 patients at an increased risk of mortality. 
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 -The prognostic value of E/E' was incremental to clinical factors and 
 conventional echocardiographic parameters of LV systolic and diastolic 
 function An elevated E/E' ratio in CS patients may be of comparable 
 value in distinguishing this select population at higher risk for poor 
 cardiovascular outcomes. 
 - So this study shows a higher reduction of  TDI indices namely S' , E' 
 and A'  in patients with CS than in patients with CHF.  
 Current guidelines do not recommend index echocardiogram for patients 
admitted for unequivocal AMI. But recent studies advocate to perform index 
bedside Doppler echocardiography especially, Tissue Doppler Imaging in the 
modern era of AMI management. 
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PROFORMA 
 
   
 NAME:                     AGE/SEX:                   CD.NO:                       DOA: 
 
 
ADDRESS:               OCCUPATION:  
 
 
HISTORY: PRESENT PAST  
 
 
RISK FACTORS:  DM:      HT:     SMOKING:     DYSLIPIDEMIA: 
 
 
O/E:        PR:   BP:  CVS:  RS: 
 
OTHER SYSTEMS: 
                                           
 
DIAGNOSIS: 
 
 
ECG 
 
 
BLOOD INVESTIGATIONS : BASELINE     RFT           LIPID PROFILE 
 
BLOOD SUGAR CARDIAC ENZYMES 
 
 
TREATMENT GIVEN: 
 
 
 
ECHOCARDIOGRAPHY: 
 
 
 
 
 
                   
 
                    
 68
GLOSSARY 
CAD  Coronary Artery Disease 
ACS  Acute Coronary Syndrome 
AMI  Acute Myocardial Infarction 
STEMI ST Elevation Myocardial Infarction 
CS  Cardiogenic Shock 
CCU  Coronary Care Unit 
CABG Coronary Artery Bypass Graft 
IVRT  Isovolumic Relaxation Time  
MR  Mitral Regurgitation 
SHOCK Should we emergently revascularize Occluded Coronaries in 
Cardiogenic Shock? 
PCWP Pulmonary Capillary Wedge Pressure 
PW                Pulse Wave 
PNF Pseudonormal Filling  
TDI               Tissue Doppler Imaging 
DT                 Deceleration Time  
Ea                  Early diastolic velocity at mitral annulus  
EF                 Ejection Fraction  
HF                 Heart failure  
LV                 Left ventricle  
LVEF            Left ventricular ejection fraction  
Sa                  Peak systolic velocity at mitral annulus  
Aa                 Late diastolic velocity at mitral annulus 
Em                Early diastolic velocity at myocardial segments 
Sm                Peak systolic velocity at myocardial segments 
S.No. Name Age Sex C.D.No. DM HT Dys Smoking LVIDd mm LVEF % MR E cm/s A cm/s E/A S' cm/s E' cm/s A 'cm/s E/E' Survivors
1 John 60 M 186160 Y Y N Y 58 25 N 66 70 0.9 3 3.6 3.1 18.3
2 Kalim 70 M 18224 Y N Y Y 57 20 N 78 56 1.3 2.9 3.3 3 23.6 Died
3 Chockalingam 64 M 185402 N Y N Y 59 21 <2 77 60 1.2 2.8 3.7 2.2 20 Died
4 Kannammal 70 F 185384 Y Y Y N 50 25 N 66 54 1.2 3.1 3 3.4 22
5 Sowki fasman 50 M    14987/09 Y Y Y Y 55 27 N 67 70 0.9 3 3.3 3.5 20.3
6 Annamalai 52 M 185412 N N N Y 60 24 <2 75 72 1 2.8 3.5 2.2 21.4 Died
7 Sambasivam 55 M 185330 Y Y Y Y 57 30 N 64 76 0.8 3.2 3.6 4 17.7
8 Kamala 65 F 187338 Y Y Y N 59 25 ≥2 78 58 1.3 2.2 3.4 2.5 22.9 Died
9 Durai 60 M 187325 N Y N Y 58 24 N 76 70 1 2.3 3.3 2.7 23 Died
10 Loganathan 59 M 185335 Y N N N 55 29 N 64 70 0.9 3.4 3.7 3.2 17.29
11 Sivananthan 65 M 188174 Y Y Y Y 55 24 <2 76 69 1.1 24 3.9 3 19 Died
12 Kokila 63 F 18565 N Y N N 56 30 N 66 67 0.9 3.8 3.8 3.1 17.36
13 Veerappan 63 M 28028 Y Y Y N 56 22 N 78 70 1.1 2.5 3.8 3.1 20 Died
14 Ismail 60 M 190756 Y N N Y 58 21 ≥2 77 66 1.1 2.5 3.7 4 20.8 Died
15 Sowry 50 M 167550 N Y N Y 60 27 N 65 70 0.9 3.7 3.9 2.9 16
16 Durairaj 62 M 38993 Y Y Y N 59 23 N 78 70 1.1 2.6 3.9 3.3 20 Died
17 Shantha kumar 52 M 185356 Y N N Y 60 28 N 64 56 0.9 3.8 4.1 2.9 15
18 Thirupandeeran 65 M 192606 N Y N Y 59 20 <2 77 68 1.1 2.3 3.8 3.1 20.2 Died
19 S.K.Rao 70 M 195112 Y Y Y N 55 21 N 76 69 1.1 2.2 4 4 19 Died
20 Daisy 65 F 185406 Y Y Y N 60 28 N 65 67 0.9 3.7 4.1 3 15.8
21 Sivananthan 65 M 188174 Y Y Y Y 57 22 N 75 54 1.3 2.7 3.2 2.9 23 Died
22 Sounderaju 50 M 20752 N N N Y 61 29 N 65 66 0.9 3.6 4 4.1 16.25
23 Siddharth 52 M      7946/10 N Y N Y 59 25 ≥2 77 61 1.2 2.9 3.9 3 19.7 Died
24 Karunanithi 46 M 188174 Y Y Y Y 56 24 N 78 69 1.1 2.6 3.4 3 22 Died
25 Mani 50 M 185312 Y Y Y N 55 25 <2 76 68 1.1 2.5 3.7 3.5 20.5 Died
26 Dhavaman 70 M 235804 N Y N Y 59 20 N 70 71 0.9 2.9 3.8 3.7 18 Died
27 Kesavan 72 M 190004 Y Y Y N 58 23 ≥2 75 66 1.1 2.4 3.1 2.7 24 Died
28 Mahimraj 46 M 10855 Y Y Y Y 57 25 N 78 59 1.3 2.7 4 2.5 19.5 Died
29 Abdul rehuman 57 M    27190/10 N Y N Y 60 27 N 66 70 0.9 3.1 3.9 3 16
30 Balakrishnan 65 M 185343 Y Y Y N 58 24 <2 66 67 0.9 2.2 3.6 2.4 18.3 Died
MASTER CHART GROUP II
Y= YES ,N=NO
